176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
85.51%
Net income growth above 1.5x TSM's 38.31%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
29.38%
D&A growth well above TSM's 41.18%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
91.86%
Well above TSM's 126.06% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
41.22%
Some inventory rise while TSM is negative at -16.04%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
482.80%
Growth well above TSM's 175.89%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
4013.65%
Some yoy increase while TSM is negative at -329.78%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
22750.46%
Operating cash flow growth above 1.5x TSM's 45.76%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-27.89%
Both yoy lines negative, with TSM at -111.87%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-72.79%
Both yoy lines negative, with TSM at -24.03%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-11.00%
We reduce yoy sales while TSM is 144.12%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-482.88%
Both yoy lines negative, with TSM at -73.96%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
5.83%
Lower share issuance yoy vs. TSM's 1959.02%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
No Data
No Data available this quarter, please select a different quarter.